New combo therapy offers hope for Tough-to-Treat gout

NCT ID NCT04762498

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times

Summary

This study tested a gout medication called pegloticase (KRYSTEXXA) given every 4 weeks along with weekly methotrexate in 50 adults with chronic gout that did not respond to standard treatments. The goal was to see if this combination could lower uric acid levels and be safe. Results help determine the best dose for future studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UNCONTROLLED GOUT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Altoona Center for Clinical Research

    Duncansville, Pennsylvania, 16635, United States

  • Arizona Arthritis & Rheumatology Research, PLLC

    Glendale, Arizona, 85306, United States

  • Arthritis Clinic: Western Washington Medical Group

    Bothell, Washington, 98021, United States

  • Arthritis Northwest PLLC

    Spokane, Washington, 99204, United States

  • Biopharma Informatic, LLC

    Houston, Texas, 77043, United States

  • East Bay Rheumatology Medical Group, Inc.

    San Leandro, California, 94578, United States

  • GCP Clinical Research

    Tampa, Florida, 33064, United States

  • Napa Research Center

    Pompano Beach, Florida, 33064, United States

  • Orthopedic Physicians Alaska

    Anchorage, Alaska, 99508, United States

  • ProHealth Research Center

    Doral, Florida, 33166, United States

  • Shelby Clinical Research, LLC

    Shelby, North Carolina, 28150, United States

  • The Center for Rheumatology and Bone Research

    Wheaton, Maryland, 20902, United States

Conditions

Explore the condition pages connected to this study.